| MeSH term | MeSH ID | Detail |
|---|---|---|
| Acne Vulgaris | D000152 | 35 associated lipids |
| Cell Transformation, Neoplastic | D002471 | 126 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Lymphoma, Large-Cell, Anaplastic | D017728 | 3 associated lipids |
Total
4
13-cis-retinoic acid,Isotretinoin
13-cis-retinoic acid,isotretinoin is a lipid of Prenol Lipids (PR) class. 13-cis-retinoic acid,isotretinoin is associated with abnormalities such as Dermatitis, Phototoxic. The involved functions are known as Regulation, Pigment, chromophore, Light absorption and Pupil constriction. 13-cis-retinoic acid,isotretinoin often locates in Neurosecretory Systems. The associated genes with 13-cis-retinoic acid,Isotretinoin are melanopsin.
Cross Reference
Introduction
To understand associated biological information of 13-cis-retinoic acid,Isotretinoin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 13-cis-retinoic acid,Isotretinoin?
13-cis-retinoic acid,Isotretinoin is suspected in Dermatitis, Phototoxic and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 13-cis-retinoic acid,Isotretinoin
PubChem Associated disorders and diseases
What pathways are associated with 13-cis-retinoic acid,Isotretinoin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 13-cis-retinoic acid,Isotretinoin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 13-cis-retinoic acid,Isotretinoin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 13-cis-retinoic acid,Isotretinoin?
There are no associated biomedical information in the current reference collection.
What genes are associated with 13-cis-retinoic acid,Isotretinoin?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 13-cis-retinoic acid,Isotretinoin?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with 13-cis-retinoic acid,Isotretinoin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Hur J et al. | Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. | 2015 | Chem. Res. Toxicol. | pmid:25811541 |
| Mora J et al. | Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7). | 2015 | Clin Transl Oncol | pmid:25596034 |
| Singh A et al. | Targeted inhibition of MEK1 by cobimetinib leads to differentiation and apoptosis in neuroblastoma cells. | 2015 | J. Exp. Clin. Cancer Res. | pmid:26384788 |
| Cantarutti N et al. | Multi-drugs resistant acne rosacea in a child affected by Ataxia-Telangiectasia: successful treatment with Isotretinoin. | 2015 | Ital J Pediatr | pmid:25881033 |
| Karadag AS et al. | The effect of different doses of isotretinoin on pituitary hormones. | 2015 | Dermatology (Basel) | pmid:25721216 |
| Stieglitz E et al. | Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group. | 2015 | Pediatr Blood Cancer | pmid:25704135 |
| Güler E et al. | An unknown side effect of isotretinoin: pericardial effusion with atrial tachycardia. | 2015 | Anatol J Cardiol | pmid:25625453 |
| Karadag AS et al. | The effect of isotretinoin on retinol-binding protein 4, leptin, adiponectin and insulin resistance in acne vulgaris patients. | 2015 | Dermatology (Basel) | pmid:25573071 |
| Iwamoto FM and Lassman AB | Factorial clinical trials: a new approach to phase II neuro-oncology studies. | 2015 | Neuro-oncology | pmid:25452393 |
| Krishna S et al. | Influence of ω-3 fatty acids on triglyceride levels in patients using isotretinoin. | 2015 | JAMA Dermatol | pmid:25251777 |
| Penas-Prado M et al. | Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma. | 2015 | Neuro-oncology | pmid:25239666 |
| Ratajewski M et al. | Screening of a chemical library reveals novel PXR-activating pharmacologic compounds. | 2015 | Toxicol. Lett. | pmid:25455453 |
| Bravo BS et al. | Oral isotretinoin in photoaging: objective histological evidence of efficacy and durability. | 2015 Jul-Aug | An Bras Dermatol | pmid:26375216 |
| Tagliolatto S et al. | Sebaceous hyperplasia: systemic treatment with isotretinoin. | 2015 Mar-Apr | An Bras Dermatol | pmid:25830991 |
| Kraemer KH and DiGiovanna JJ | Forty years of research on xeroderma pigmentosum at the US National Institutes of Health. | 2015 Mar-Apr | Photochem. Photobiol. | pmid:25220021 |
| Gupta D et al. | Keratosis follicularis spinulosa decalvans showing excellent response to isotretinoin. | 2015 Nov-Dec | Indian J Dermatol Venereol Leprol | pmid:26515859 |
| Leyden J | Recent advances in the use of adapalene 0.1%/benzoyl peroxide 2.5% to treat patients with moderate to severe acne. | 2016 | J Dermatolog Treat | pmid:26947815 |
| Yeo PM et al. | Paradoxical Worsening of Truncal Acne with Doxycycline. | 2016 | Ann. Acad. Med. Singap. | pmid:27748793 |
| Szychot E et al. | Evidence for the efficacy of immunotherapy in children with high-risk neuroblastoma. | 2016 | Postepy Hig Med Dosw (Online) | pmid:27708204 |
| Schaller M and Gonser L | A Tailored Approach to the Treatment of a Patient with a Severe Dynamic Manifestation of Rosacea: A Case Report. | 2016 | Drugs R D | pmid:27623792 |